Global Bioprocess Controllers and Automation Systems Market (2021 to 2030) - Featuring Agilitech, BIONET and Clorox Among Others - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Bioprocess Controllers and Automation Systems Market By Type of Controllers, Scale of Operation, Types of Processes Controlled, Mode of Operation, Compatibility with Bioprocessing Systems, and Key Geographical Regions: Industry Trends and Global Forecasts, 2021-2030" report has been added to ResearchAndMarkets.com's offering.

This report features an extensive study of the current landscape and the likely future potential of bioprocess controllers and automation systems, over the next decade. The study also features an in-depth analysis, highlighting the capabilities of various industry stakeholders engaged in this field.

Over the past few decades, biopharmaceuticals have gained significant popularity owing to their therapeutic efficacy, favorable safety profiles and ability to treat a wide variety of disease indications, which are otherwise hard to treat. The success of these interventions has prompted the stakeholders to upgrade the conventional biologics manufacturing equipment.

As a result, the domain has witnessed several technological advancements, including the adoption of controllers and automated systems. These systems not only ensure that the processes continue to run within precise limits but also make the necessary adjustments, while minimizing the risk of human errors and improving the product quality. Additionally, these controllers and automation systems have the potential to address a number of challenges associated with traditional bioprocessing systems and offer various additional benefits, such as lowering of production and labor cost (by 20-30%), optimizing the energy consumption (by 5-30%) and increasing the overall productivity (by 10-20%).

Given the various advantages of controllers and automated systems, biopharmaceutical developers and manufacturers are steadily adopting such solutions. Moreover, the recent surge in demand for vaccines amidst the ongoing COVID-19 pandemic has also prompted the biopharmaceutical companies to develop automation systems for producing drugs at a faster pace. In addition, several equipment manufacturers offering more user-friendly, controlled, and automated systems, have emerged.

In fact, the field has been witnessing a lot of innovations, evident from the number of patents filed for the controllers and automation systems. These controllers and automated systems use process analytical technological tools that can be easily integrated in the bioprocessing unit to improve scalability. Stakeholders have also been focusing on making further improvements and have incorporated a variety of key features, including provisions for alerts/alarms, built-in system process control sensors, remote monitoring features, visual display, and advanced safety provisions. Owing to the rising interest of stakeholders towards technological advancement and adoption of these systems, we believe that the overall bioreactor controller and automation systems market is anticipated to witness substantial growth in the coming years.

Companies Mentioned

• Agilitech
• Amgen
• Andrew Alliance (acquired by Waters)
• Applikon Biotechnology (acquired by Getinge)
• ARTeSYN Biosolutions (acquired by Repligen)
• Automated Control Concepts (ACC)
• Bioengineering
• BIONET
• Bioreactors.net
• BlueSens gas sensor
• Clorox
• CSL
• Curexsys
• Cytiva (acquired by Danaher)
• DISTek
• Duke University
• Eppendorf
• Flotek
• Flownamics
• General Electric (GE)
• Getinge
• GoSilico (acquired by Cytiva)
• Harvard Business School
• ILS Automation
• INFORS HT
• Inscripta
• J. Craig Venter Institute (JCVI)
• LAMBDA Laboratory Instruments
• Lonza
• Massachusetts Institute of Technology (MIT)
• Medtronic
• Merck Millipore
• Novasep
• Pall (acquired by Danaher)
• Parker Hannifin
• PendoTECH
• Pierre Guerin
• Plus Therapeutics (formerly Cytori Therapeutics)
• Princeton University
• Procter & Gamble (P&G)
• Propel Labs
• Repligen
• Roche
• Rockwell Automation
• Sartorius Stedim Biotech
• Securecell
• Sepragen
• Solaris Biotechnology
• Solida Biotech
• SYSBIOTECH
• Terumo Blood and Cell Technologies
• Thermo Fisher Scientific
• University of California
• University of Maryland
• University of Missouri
• Vanderbilt University
• VERDOT Ips
• WaterSep BioSeparations (acquired by Sartorius)
• Xyleco

Key Questions Answered

• Who are the leading players engaged in the development of bioprocess controller and automation systems?
• What are the different application areas where bioprocess controller and automation systems can be used?
• What are the key features of bioprocess controller and automation systems?
• How has the intellectual property landscape of bioprocess controller and automation, evolved over the years?
• What are the key trends within the bioprocess controllers and automation systems market?
• How is the current and future opportunity likely to be distributed across key market segments?

Key Topics Covered:

1. PREFACE

2. EXECUTIVE SUMMARY

3. INTRODUCTION

4. MARKET LANDSCAPE: UPSTREAM CONTROLLERS

5. MARKET LANDSCAPE: DOWNSTREAM CONTROLLER SYSTEMS

6. MARKET LANDSCAPE: BIOPROCESS CONTROL SOFTWARE

7. PRODUCT COMPETITIVENESS ANALYSIS

8. BIOPROCESS CONTROLLER AND AUTOMATION SYSTEM DEVELOPERS IN NORTH AMERICA: COMPANY PROFILES

9. BIOPROCESS CONTROLLER AND AUTOMATION SYSTEM DEVELOPERS IN EUROPE: COMPANY PROFILES

10. MARKET TREND ANALYSIS

11. PATENT ANALYSIS

12. BRAND POSITIONING ANALYSIS

13. MARKET FORECAST AND OPPORTUNITY ANALYSIS

14. CONCLUSION

15. EXECUTIVE INSIGHTS

16. APPENDIX 1: TABULATED DATA

17. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

For more information about this report visit https://www.researchandmarkets.com/r/l1jfno